Consultation and management of patients with lipid disorders: Importance of life-style changes and intensive follow-up

Connecticut Medicine

Volumn 70, Issue 3, 2006, Pages 133-139

  Karwacki Marugg, Claire L ^a,d   Schnatz, J David ^a,b,c  

^a Hoffman Heart Inst of Connecticut   (United States)

^b Saint Francis Hospital and Medical Center   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d Mailstop #50202   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY MASS; CONSULTATION; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; LIFESTYLE; LIPID BLOOD LEVEL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MUSCLE TONE; QUESTIONNAIRE;

CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; LIFE STYLE; MALE; MIDDLE AGED; PATIENT EDUCATION; REFERRAL AND CONSULTATION; TRIGLYCERIDES; WEIGHT LOSS;

EID: 33645454770     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. American Heart Association: Heart disease and stroke statistics-2004 update. Available at http://www.americanheart.org/presenter. html?identifier=1200000.
2. The Expert Panel: Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148:36-69.
3. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994; 89:1333-445.
4. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
5. Grundy SM, Cleeman JI, Merz CN, et al: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110:227-39.
6. Schrott HG, Bittner V, Vittinghoff E, et al: Adherence to National Cholesterol Education Program treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). JAMA 1997; 277:1281-6.
7. Bramlet DA, King H, Young L, et al: Management of hypercholesterolemia: Practice patterns for primary care providers and cardiologists. Am J Cardiol 1997; 80(8B):39H-44H.
8. Allison TG, Squires RW, Johnson BD, Gau GT: Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: Importance of diet, exercise, weight control and drug therapy. Mayo Clin Proc 1999; 74:466-73.
9. Majumdar SR, Gurwitz JH, Soumerai SB: Undertreatmentof hyperlipidemia in the secondary prevention of coronary artery disease. J Gen Intern Med 1999; 14:711-17.
10. Brown AS, Cofer LA: Lipid management in a private cardiology practice (The Midwest Heart Experience). Am J Cardiol 2000; 85:18A-22A.
11. Robinson JG, Conroy C, Wickemeyer WJ: A novel telephone-based system for management of secondary prevention to a low-density lipoprotein cholesterol =100 mg/dl. Am J Cardiol 2000; 85:305-8.
12. Pearson TA, Laurora I, Chu H, Kafonek S: The lipid treatment assessment project (L-Tap). A multicenter survey to evaluate percent-ages of dyslipidemia patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000; 160:459-67.
13. Latts LM: Assessing the results: Phase I hyperlipidemia outcomes in 27 health plans. Am J Med 2001; 110(6A):17(S)-23(S).
14. Yates S, Annis L, Pippins J, Walden S: Does a lipid clinic increase compliance with National Cholesterol Education Program Treatment guidelines? Report of a case-matched controlled study. South Med J 2001; 94:907-909.
15. Cording MA, Engelbrecht-Zadvorny EB, Pettit BJ, et al: Development of a pharmacist-managed lipid clinic. Ann Pharmacother 2002; 36:892-904.
16. Frolkis JP, Pearce GL, Nambi V, et al: Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice. Am J Med 2002; 113:625-9.
17. Vale MJ, Jelinek MV, Best JD, Santamaria JD: Coaching patients with coronary heart disease to achieve the target cholesterol: A method to bridge the gap between evidence-based medicine and the "real world"- randomized controlled trial. J Clin Epid 2002; 55:245-52.
18. Ali F, Laurin MY, Lariviere C, et al: The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol 2003; 10:101-106.
19. Tsuyuki RT, Olson KL, Dubyk AM, et al: Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: The second study of cardiovascular risk intervention by pharmacists (SCRIP-plus). Am J Med 2004; 116:130-3.
20. Lichtman JH, Amatruda J, Yaari S, et al: Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease. Am Heart J 2004; 147:522-8.
21. Shaffer J, Wexler LF: Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care. Arch Intern Med 1995; 155:2330-5.
22. Quick Check for diet progress [form]. Nutrition Scientific 1994.
23. Harris JA, Benedict FG: A biometric study of basal metabolism in man. Washington D.C: Carnegie Institute of Washington; 1919. Publication; 279.
24. SAS Institute, Inc.: SAS/STAT User's Guide. Version 6, Fourth Edition. Cary, NC: 1990.
25. Girman CJ, Rhodes T, Mercuri M, et al: The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Events Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004; 93:136-41.
26. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among U.S. adults, 1999-2000. JAMA 2002; 288:1723-7.
27. Ornish D, Brown SE, Scherwitz LW, et al: Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336:129-33.
28. Haskell WL, Alderman EL, Fair JM, et al: Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994; 89:975-90.